RA
MRNA icon

Ransom Advisory’s Moderna MRNA Stock Holding History

Ransom Advisory’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-150
Closed -$4.25K – 331
2025
Q1 		$4.25K Hold
150
– – ﹤0.01% 298
2024
Q4 		$6.24K Hold
150
– – ﹤0.01% 367
2024
Q3 		$10K Hold
150
– – ﹤0.01% 354
2024
Q2 		$17.8K Hold
150
– – 0.01% 304
2024
Q1 		$16K Buy
+150
New +$15.1K 0.01% 261

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Ransom Advisory's MRNA Position: Q2 2025 in Review

Ransom Advisory sold out of Moderna (MRNA) in Q2 2025, closing a stake of 150 shares — an estimated $4.25K sold.

Ransom Advisory first reported a position in MRNA in Q1 2024 and held it in 5 quarters. The position peaked at $17.8K in Q2 2024. 674 funds tracked by Wall St. Rank hold MRNA as of Q2 2025.

  • Ransom Advisory reported no remaining Moderna position as of Q2 2025 after selling out during the quarter.
  • Ransom Advisory sold 150 Moderna shares in Q2 2025, an estimated $4.25K.
  • Ransom Advisory first reported a position in Moderna in Q1 2024 and held it in 5 quarters.
  • Ransom Advisory's Moderna position peaked at $17.8K in Q2 2024.
  • 674 funds tracked by Wall St. Rank held Moderna as of Q2 2025.

Based on Ransom Advisory's 13F filing for Q2 2025, filed 8 Jul 2025.